Coherus Free Cash Flow Yield vs Free Cash Flow Analysis

CHRS Stock  USD 1.70  0.09  5.59%   
Coherus BioSciences financial indicator trend analysis is way more than just evaluating Coherus BioSciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Coherus BioSciences is a good investment. Please check the relationship between Coherus BioSciences Free Cash Flow Yield and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coherus BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Coherus Stock please use our How to Invest in Coherus BioSciences guide.

Free Cash Flow Yield vs Free Cash Flow

Free Cash Flow Yield vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Coherus BioSciences Free Cash Flow Yield account and Free Cash Flow. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Coherus BioSciences' Free Cash Flow Yield and Free Cash Flow is 0.82. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Coherus BioSciences, assuming nothing else is changed. The correlation between historical values of Coherus BioSciences' Free Cash Flow Yield and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Coherus BioSciences are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Free Cash Flow Yield i.e., Coherus BioSciences' Free Cash Flow Yield and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.82
Relationship DirectionPositive 
Relationship StrengthStrong

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most indicators from Coherus BioSciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Coherus BioSciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coherus BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Coherus Stock please use our How to Invest in Coherus BioSciences guide.Selling General Administrative is likely to drop to about 100.1 M in 2024. Tax Provision is likely to gain to about (361 K) in 2024
 2021 2022 2023 2024 (projected)
Interest Expense23.0M32.5M40.5M42.6M
Depreciation And Amortization5.7M3.7M3.8M2.0M

Coherus BioSciences fundamental ratios Correlations

0.830.860.660.49-0.040.010.76-0.40.46-0.880.670.550.590.610.780.630.70.960.330.880.740.710.980.770.9
0.830.930.690.470.220.340.72-0.320.29-0.680.510.810.550.580.840.880.760.770.250.930.860.790.80.820.88
0.860.930.760.52-0.10.160.58-0.370.56-0.820.510.580.650.720.880.70.780.840.520.980.90.90.870.890.96
0.660.690.760.91-0.43-0.10.4-0.430.77-0.830.510.340.90.810.920.40.970.620.270.70.620.890.660.950.69
0.490.470.520.91-0.53-0.080.36-0.140.66-0.720.650.170.940.830.740.180.870.490.070.480.30.690.490.820.49
-0.040.22-0.1-0.43-0.530.460.340.04-0.790.41-0.180.63-0.53-0.49-0.220.54-0.28-0.1-0.44-0.030.06-0.33-0.1-0.32-0.11
0.010.340.16-0.1-0.080.460.150.62-0.520.160.150.61-0.070.07-0.050.57-0.07-0.02-0.220.240.090.0-0.030.070.11
0.760.720.580.40.360.340.15-0.120.06-0.570.670.680.450.460.570.70.530.740.040.650.480.430.720.530.66
-0.4-0.32-0.37-0.43-0.140.040.62-0.12-0.490.420.16-0.12-0.16-0.05-0.49-0.16-0.44-0.35-0.21-0.29-0.52-0.41-0.43-0.35-0.33
0.460.290.560.770.66-0.79-0.520.06-0.49-0.750.25-0.220.720.670.71-0.080.690.480.660.490.490.770.520.710.55
-0.88-0.68-0.82-0.83-0.720.410.16-0.570.42-0.75-0.64-0.32-0.82-0.82-0.85-0.42-0.81-0.91-0.45-0.81-0.66-0.82-0.92-0.89-0.85
0.670.510.510.510.65-0.180.150.670.160.25-0.640.290.680.690.470.290.540.72-0.030.560.230.380.660.550.59
0.550.810.580.340.170.630.610.68-0.12-0.22-0.320.290.230.280.480.980.430.47-0.160.620.560.40.50.490.53
0.590.550.650.90.94-0.53-0.070.45-0.160.72-0.820.680.230.950.780.280.850.630.240.610.390.760.610.880.63
0.610.580.720.810.83-0.490.070.46-0.050.67-0.820.690.280.950.730.360.750.680.380.690.430.770.640.860.71
0.780.840.880.920.74-0.22-0.050.57-0.490.71-0.850.470.480.780.730.580.960.730.450.860.850.960.780.960.84
0.630.880.70.40.180.540.570.7-0.16-0.08-0.420.290.980.280.360.580.480.560.070.740.690.540.590.580.66
0.70.760.780.970.87-0.28-0.070.53-0.440.69-0.810.540.430.850.750.960.480.650.250.740.690.890.690.940.72
0.960.770.840.620.49-0.1-0.020.74-0.350.48-0.910.720.470.630.680.730.560.650.370.860.660.680.980.740.89
0.330.250.520.270.07-0.44-0.220.04-0.210.66-0.45-0.03-0.160.240.380.450.070.250.370.520.580.620.380.410.55
0.880.930.980.70.48-0.030.240.65-0.290.49-0.810.560.620.610.690.860.740.740.860.520.90.870.880.860.98
0.740.860.90.620.30.060.090.48-0.520.49-0.660.230.560.390.430.850.690.690.660.580.90.850.740.760.87
0.710.790.90.890.69-0.330.00.43-0.410.77-0.820.380.40.760.770.960.540.890.680.620.870.850.720.960.85
0.980.80.870.660.49-0.1-0.030.72-0.430.52-0.920.660.50.610.640.780.590.690.980.380.880.740.720.780.92
0.770.820.890.950.82-0.320.070.53-0.350.71-0.890.550.490.880.860.960.580.940.740.410.860.760.960.780.85
0.90.880.960.690.49-0.110.110.66-0.330.55-0.850.590.530.630.710.840.660.720.890.550.980.870.850.920.85
Click cells to compare fundamentals

Coherus BioSciences Account Relationship Matchups

Coherus BioSciences fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding73.2M83.5M75.4M77.6M94.2M54.8M
Total Assets408.9M841.6M679.3M480.8M629.6M362.5M
Short Long Term Debt Total180.6M404.0M408.3M471.1M480.8M248.2M
Other Current Liab89.0M127.3M145.7M122.9M294.4M309.1M
Total Current Liabilities115.0M81.5M79.0M54.5M331.8M348.4M
Total Stockholder Equity105.2M281.0M97.7M(137.4M)(193.4M)(183.8M)
Other Liab102K75.1M94.3M3.5M4.0M3.8M
Property Plant And Equipment Net16.5M20.1M7.8M8.8M11.0M10.3M
Net Debt718K(137.1M)(8.9M)407.5M378.0M396.8M
Retained Earnings(895.0M)(762.8M)(1.0B)(1.3B)(1.6B)(1.5B)
Accounts Payable26.0M15.2M16.2M11.5M35.2M18.7M
Cash177.7M541.2M417.2M63.5M102.9M182.4M
Non Current Assets Total34.2M51.3M45.9M64.2M154.0M161.7M
Non Currrent Assets Other14.1M27.6M34.5M49.5M71.3M74.8M
Other Assets45.9M60.5M45.9M64.2M73.8M77.5M
Cash And Short Term Investments177.7M541.2M417.2M191.7M117.7M195.5M
Net Receivables142.0M157.0M123.0M110.0M260.5M273.5M
Liabilities And Stockholders Equity408.9M841.6M679.3M480.8M629.6M362.5M
Non Current Liabilities Total303.7M479.1M502.6M563.8M491.3M288.9M
Inventory55.1M92.2M93.3M115.1M62.6M41.2M
Other Current Assets13.5M25.0M24.5M40.8M34.8M36.5M
Other Stockholder Equity1.0B1.0B1.1B1.2B1.4B785.7M
Total Liab303.7M560.7M581.6M618.3M823.0M864.2M
Property Plant And Equipment Gross16.5M20.1M24.7M28.9M25.8M15.1M
Total Current Assets374.7M790.4M633.5M416.7M475.6M311.1M
Accumulated Other Comprehensive Income(282K)(558K)(270K)(249K)(248K)(260.4K)
Property Plant Equipment16.5M48.0M63.4M85.0M97.8M102.7M
Net Tangible Assets101.7M277.4M97.7M(143.3M)(164.9M)(156.6M)
Long Term Debt178.4M377.4M408.3M225.6M473.4M497.0M
Retained Earnings Total Equity(895.0M)(762.8M)(1.0B)(1.3B)(1.2B)(1.1B)
Capital Surpluse1.0B1.0B1.1B1.2B1.4B900.6M
Non Current Liabilities Other102K37.6M94.3M254.0M11.5M10.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Coherus Stock Analysis

When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.